Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.
Pierre N, Huynh-Thu VA, Baiwir D, Mazzucchelli G, Fléron M, Trzpiot L, Eppe G, De Pauw E, Laharie D, Satsangi J, Bossuyt P, Vuitton L, Vieujean S, Colombel JF, Meuwis MA, Louis E; GETAID and the SPARE-Biocycle research group. Pierre N, et al. Gut. 2024 Nov 11;73(12):1965-1973. doi: 10.1136/gutjnl-2024-332648. Gut. 2024. PMID: 39134391 Free article. Clinical Trial.
Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study.
Pierre N, Baiwir D, Huynh-Thu VA, Mazzucchelli G, Smargiasso N, De Pauw E, Bouhnik Y, Laharie D, Colombel JF, Meuwis MA, Louis E; GETAID (Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif). Pierre N, et al. Gut. 2020 Oct 26:gutjnl-2020-322100. doi: 10.1136/gutjnl-2020-322100. Online ahead of print. Gut. 2020. PMID: 33106355 Free article.
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity.
Pierre N, Huynh-Thu VA, Marichal T, Allez M, Bouhnik Y, Laharie D, Bourreille A, Colombel JF, Meuwis MA, Louis E; GETAID (Groupe d’Etude Thérapeutique des Affections Inflammatoires du tube Digestif). Pierre N, et al. Gut. 2023 Mar;72(3):443-450. doi: 10.1136/gutjnl-2022-327321. Epub 2022 Aug 25. Gut. 2023. PMID: 36008101 Free article.
Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.
Vieujean S, Hu S, Bequet E, Salee C, Massot C, Bletard N, Pierre N, Quesada Calvo F, Baiwir D, Mazzucchelli G, De Pauw E, Coimbra Marques C, Delvenne P, Rieder F, Louis E, Meuwis MA. Vieujean S, et al. Among authors: pierre n. J Crohns Colitis. 2021 Oct 7;15(10):1737-1750. doi: 10.1093/ecco-jcc/jjab061. J Crohns Colitis. 2021. PMID: 33822017 Free PMC article.
An Interprofessional Team for Disease-Modifying Therapy in Alzheimer Disease Implementation.
Turk KW, Knobel MD, Nothern A, Friedman G, Noah H, Campbell B, Anderson DC, Charidimou A, Mills A, Coronel V, Pierre N, Reynolds BV, Wagner C, Varga LM, Roefaro J, Triantafylidis L, Budson AE. Turk KW, et al. Among authors: pierre n. Neurol Clin Pract. 2024 Dec;14(6):e200346. doi: 10.1212/CPJ.0000000000200346. Epub 2024 Aug 16. Neurol Clin Pract. 2024. PMID: 39185104 Free PMC article.
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary.
Sherman EM, Agwu AL, Ambrosioni J, Behrens GMN, Chu C, Collins LF, Jimenez HR, Koren DE, McGorman L, Nguyen NN, Nicol MR, Pandit NS, Pierre N, Scarsi KK, Spinner GF, Tseng A, Young JD, Badowski ME. Sherman EM, et al. Among authors: pierre n. Pharmacotherapy. 2024 Jul;44(7):488-493. doi: 10.1002/phar.2921. Pharmacotherapy. 2024. PMID: 39005161
53 results